BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30523605)

  • 21. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
    Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy.
    Arpa D; Parisi E; Ghigi G; Savini A; Colangione SP; Tontini L; Pieri M; Foca F; Polico R; Tesei A; Sarnelli A; Romeo A
    Sci Rep; 2020 Nov; 10(1):19321. PubMed ID: 33168845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
    Lee J; Cho J; Chang JH; Suh CO
    Yonsei Med J; 2016 Jul; 57(4):824-30. PubMed ID: 27189273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-irradiation in elderly patients with glioblastoma: a single institution experience.
    Straube C; Antoni S; Gempt J; Zimmer C; Meyer B; Schlegel J; Schmidt-Graf F; Combs SE
    J Neurooncol; 2019 Apr; 142(2):327-335. PubMed ID: 30659523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review.
    Xiang X; Ji Z; Jin J
    Radiother Oncol; 2024 Jan; 190():110012. PubMed ID: 37972737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme.
    Ballman KV; Buckner JC; Brown PD; Giannini C; Flynn PJ; LaPlant BR; Jaeckle KA
    Neuro Oncol; 2007 Jan; 9(1):29-38. PubMed ID: 17108063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients.
    Kim MS; Lim J; Shin HS; Cho KG
    Brain Tumor Res Treat; 2020 Apr; 8(1):29-35. PubMed ID: 32390351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.
    Scoccianti S; Francolini G; Carta GA; Greto D; Detti B; Simontacchi G; Visani L; Baki M; Poggesi L; Bonomo P; Mangoni M; Desideri I; Pallotta S; Livi L
    Crit Rev Oncol Hematol; 2018 Jun; 126():80-91. PubMed ID: 29759570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-irradiation for recurrent glioblastoma multiforme.
    Barney C; Shukla G; Bhamidipati D; Palmer JD
    Chin Clin Oncol; 2017 Aug; 6(4):36. PubMed ID: 28841798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status and recent advances in reirradiation of glioblastoma.
    Minniti G; Niyazi M; Alongi F; Navarria P; Belka C
    Radiat Oncol; 2021 Feb; 16(1):36. PubMed ID: 33602305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report.
    Pashaki AS; Hamed EA; Mohamadian K; Abassi M; Safaei AM; Torkaman T
    Asian Pac J Cancer Prev; 2014; 15(6):2793-6. PubMed ID: 24761902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
    Pouessel D; Ken S; Gouaze-Andersson V; Piram L; Mervoyer A; Larrieu-Ciron D; Cabarrou B; Lusque A; Robert M; Frenel JS; Uro-Coste E; Olivier P; Mounier M; Sabatini U; Sanchez EH; Zouitine M; Berjaoui A; Cohen-Jonathan Moyal E
    Oncologist; 2023 Sep; 28(9):825-e817. PubMed ID: 37196069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
    Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B
    Tumori; 2015; 101(2):179-84. PubMed ID: 25791534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
    Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
    Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.